Tobias Ettl, Johannes K Meier, Peter Kummer, Fabian Pohl, Michael Gerken, Torsten E Reichert, Christopher Bohr, Sarah Vester
{"title":"Swallowing and Speaking Evaluation After Resection and Reconstruction Versus Definite Radiochemotherapy for (Sub)total Tongue Cancer.","authors":"Tobias Ettl, Johannes K Meier, Peter Kummer, Fabian Pohl, Michael Gerken, Torsten E Reichert, Christopher Bohr, Sarah Vester","doi":"10.1097/GOX.0000000000006533","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In very advanced tongue cancer, definite radiochemotherapy (RCHT) is often preferred over total or near total glossectomy due to organ preservation and functionality, particularly swallowing.</p><p><strong>Methods: </strong>This retrospective study compares the functionality and survival of 10 patients with very advanced tongue cancer who received (sub)total glossectomy with prior or adjuvant RCHT and reconstruction by a musculocutaneous anterolateral thigh flap. All 10 patients had comparable tongue carcinomas treated by definite RCHT. Airway protection and swallow efficiency were evaluated by fiberoptic endoscopic evaluation of swallowing and graded using the Rosenbek Penetration and Aspiration Scale (PAS) and the Yale Pharyngeal Residue Severity Rating Scale (YPRS).</p><p><strong>Results: </strong>Of 10 surgical patients, 7 were completely oralized after a mean of 17 days. For surgical patients, PAS scores swallowing saliva (mean 1.6 versus 2.9, <i>P</i> = 0.04) as well as vallecula (mean 4.0 versus 2.9, <i>P</i> = 0.05) and piriform sinus (mean 3.5 versus 2.5, <i>P</i> = 0.05) YPRS scores for saliva were significantly lower compared with definite RCHT. Irrespective of treatment, age older than 65 years (YPRS sinus piriformis H<sub>2</sub>O 3.4 versus 2.5, <i>P</i> = 0.47), body mass index less than 20 kg/m<sup>2</sup> (PAS Jelly 4.7 versus 2.2, <i>P</i> = 0.015, YPRS sinus piriformis 4.0 versus 2.7, <i>P</i> = 0.028), and Karnovsky index less than 80 (PAS saliva 2.8 versus 1.6, <i>P</i> = 0.049) were associated with worse swallowing. Speech was intelligible in 80% of patients of both groups. Overall survival did not differ between the surgical group and definite RCHT.</p><p><strong>Conclusions: </strong>Patients after (sub)total glossectomy with RCHT and adequate reconstruction with a musculocutaneous anterolateral thigh flap show equal or even better swallowing compared with patients after definite RCHT for advanced tongue cancer.</p>","PeriodicalId":20149,"journal":{"name":"Plastic and Reconstructive Surgery Global Open","volume":"13 3","pages":"e6533"},"PeriodicalIF":1.5000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11908755/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Plastic and Reconstructive Surgery Global Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/GOX.0000000000006533","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: In very advanced tongue cancer, definite radiochemotherapy (RCHT) is often preferred over total or near total glossectomy due to organ preservation and functionality, particularly swallowing.
Methods: This retrospective study compares the functionality and survival of 10 patients with very advanced tongue cancer who received (sub)total glossectomy with prior or adjuvant RCHT and reconstruction by a musculocutaneous anterolateral thigh flap. All 10 patients had comparable tongue carcinomas treated by definite RCHT. Airway protection and swallow efficiency were evaluated by fiberoptic endoscopic evaluation of swallowing and graded using the Rosenbek Penetration and Aspiration Scale (PAS) and the Yale Pharyngeal Residue Severity Rating Scale (YPRS).
Results: Of 10 surgical patients, 7 were completely oralized after a mean of 17 days. For surgical patients, PAS scores swallowing saliva (mean 1.6 versus 2.9, P = 0.04) as well as vallecula (mean 4.0 versus 2.9, P = 0.05) and piriform sinus (mean 3.5 versus 2.5, P = 0.05) YPRS scores for saliva were significantly lower compared with definite RCHT. Irrespective of treatment, age older than 65 years (YPRS sinus piriformis H2O 3.4 versus 2.5, P = 0.47), body mass index less than 20 kg/m2 (PAS Jelly 4.7 versus 2.2, P = 0.015, YPRS sinus piriformis 4.0 versus 2.7, P = 0.028), and Karnovsky index less than 80 (PAS saliva 2.8 versus 1.6, P = 0.049) were associated with worse swallowing. Speech was intelligible in 80% of patients of both groups. Overall survival did not differ between the surgical group and definite RCHT.
Conclusions: Patients after (sub)total glossectomy with RCHT and adequate reconstruction with a musculocutaneous anterolateral thigh flap show equal or even better swallowing compared with patients after definite RCHT for advanced tongue cancer.
期刊介绍:
Plastic and Reconstructive Surgery—Global Open is an open access, peer reviewed, international journal focusing on global plastic and reconstructive surgery.Plastic and Reconstructive Surgery—Global Open publishes on all areas of plastic and reconstructive surgery, including basic science/experimental studies pertinent to the field and also clinical articles on such topics as: breast reconstruction, head and neck surgery, pediatric and craniofacial surgery, hand and microsurgery, wound healing, and cosmetic and aesthetic surgery. Clinical studies, experimental articles, ideas and innovations, and techniques and case reports are all welcome article types. Manuscript submission is open to all surgeons, researchers, and other health care providers world-wide who wish to communicate their research results on topics related to plastic and reconstructive surgery. Furthermore, Plastic and Reconstructive Surgery—Global Open, a complimentary journal to Plastic and Reconstructive Surgery, provides an open access venue for the publication of those research studies sponsored by private and public funding agencies that require open access publication of study results. Its mission is to disseminate high quality, peer reviewed research in plastic and reconstructive surgery to the widest possible global audience, through an open access platform. As an open access journal, Plastic and Reconstructive Surgery—Global Open offers its content for free to any viewer. Authors of articles retain their copyright to the materials published. Additionally, Plastic and Reconstructive Surgery—Global Open provides rapid review and publication of accepted papers.